Clinical Trials · NCT01753297

A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

Name: A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Gonadorelin

Phase: Phase 4
Recruitment status: Completed
Sponsor: Ipsen
Enrollment: 226
Start date: Dec 2012
Locations: 18 sites, China, Russia
Primary endpoint: Number of Subjects With BR Events

View Gonadorelin compound reference